New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
A new approach for detecting tumor heterogeneity to assess breast cancer patient outcomes

A new approach for detecting tumor heterogeneity to assess breast cancer patient outcomes

byDartmouth-Hitchcock Medical CenterNovel approach to identify and quantify tumor heterogeneity reveals the presence of high levels of diversity within breast tumors. Credit: Diwakar R. Pattabir
World medicine December 16,2023
A new approach for detecting tumor heterogeneity to assess breast cancer patient outcomes

A new approach for detecting tumor heterogeneity to assess breast cancer patient outcomes

byDartmouth-Hitchcock Medical CenterNovel approach to identify and quantify tumor heterogeneity reveals the presence of high levels of diversity within breast tumors. Credit: Diwakar R. Pattabir
World medicine December 16,2023
Novel T cell bispecific antibody shows potent anti-tumor activity in preclinical models of glioblastoma

Novel T cell bispecific antibody shows potent anti-tumor activity in preclinical models of glioblastoma

by Vall d'Hebron Institute of OncologyGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Glioblastoma multiforme (GBM) is one of the most aggressive, fast-growing tumor types, and the m
World medicine December 16,2023
Novel T cell bispecific antibody shows potent anti-tumor activity in preclinical models of glioblastoma

Novel T cell bispecific antibody shows potent anti-tumor activity in preclinical models of glioblastoma

by Vall d'Hebron Institute of OncologyGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Glioblastoma multiforme (GBM) is one of the most aggressive, fast-growing tumor types, and the m
World medicine December 16,2023
Understanding why deadly brain cancer comes back

Understanding why deadly brain cancer comes back

byUniversity of LeedsGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.04.038The deadliest form of brain cancer returns because tumors adapt to treatment by recruiting
World medicine December 16,2023
Understanding why deadly brain cancer comes back

Understanding why deadly brain cancer comes back

byUniversity of LeedsGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.04.038The deadliest form of brain cancer returns because tumors adapt to treatment by recruiting
World medicine December 16,2023
How common genetic alterations cause kidney cancer

How common genetic alterations cause kidney cancer

byUniversity of HelsinkiChromatin level interaction between the renal lineage factor PAX8 and oncogenic HIF2A in ccRCC. a,b, Pooled CRISPR–Cas9 loss-of-function screen results of ccRCC cell line
World medicine December 16,2023
How common genetic alterations cause kidney cancer

How common genetic alterations cause kidney cancer

byUniversity of HelsinkiChromatin level interaction between the renal lineage factor PAX8 and oncogenic HIF2A in ccRCC. a,b, Pooled CRISPR–Cas9 loss-of-function screen results of ccRCC cell line
World medicine December 16,2023
More accurate prediction of cancer risk in individuals with Li-Fraumeni syndrome

More accurate prediction of cancer risk in individuals with Li-Fraumeni syndrome

by Medizinische Hochschule HannoverSpectrum of TP53 germline variants and statistically significant genotype-phenotype correlations. Colored spheres refer to different patients harboring the correspon
World medicine December 16,2023
More accurate prediction of cancer risk in individuals with Li-Fraumeni syndrome

More accurate prediction of cancer risk in individuals with Li-Fraumeni syndrome

by Medizinische Hochschule HannoverSpectrum of TP53 germline variants and statistically significant genotype-phenotype correlations. Colored spheres refer to different patients harboring the correspon
World medicine December 16,2023
Long-term benefit of combining chemotherapy and radiotherapy in bladder cancer

Long-term benefit of combining chemotherapy and radiotherapy in bladder cancer

byInstitute of Cancer ResearchImage of a mouse bladder after surgery to remove a tumour. Credit:Frank C. MariniGiving people with bladder cancer chemotherapy and radiotherapy at the same t
World medicine December 16,2023
Long-term benefit of combining chemotherapy and radiotherapy in bladder cancer

Long-term benefit of combining chemotherapy and radiotherapy in bladder cancer

byInstitute of Cancer ResearchImage of a mouse bladder after surgery to remove a tumour. Credit:Frank C. MariniGiving people with bladder cancer chemotherapy and radiotherapy at the same t
World medicine December 16,2023
A better roadmap for beating deadly leukemia

A better roadmap for beating deadly leukemia

by Joe Rojas-Burke,Oregon Health & Science UniversityGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.07.002Acute myeloid leukemia, or AML, is the most com
World medicine December 16,2023
A better roadmap for beating deadly leukemia

A better roadmap for beating deadly leukemia

by Joe Rojas-Burke,Oregon Health & Science UniversityGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.07.002Acute myeloid leukemia, or AML, is the most com
World medicine December 16,2023
Survey finds uneven training in cannabis therapy among cannabis dispensary staff

Survey finds uneven training in cannabis therapy among cannabis dispensary staff

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainWith research suggesting that many patients with cancer are using cannabis for medical purposes—and oncology teams tending to offer
World medicine December 16,2023
Survey finds uneven training in cannabis therapy among cannabis dispensary staff

Survey finds uneven training in cannabis therapy among cannabis dispensary staff

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainWith research suggesting that many patients with cancer are using cannabis for medical purposes—and oncology teams tending to offer
World medicine December 16,2023
HER2-low metastatic breast cancer patients report preserved quality of life with trastuzumab deruxtecan treatment

HER2-low metastatic breast cancer patients report preserved quality of life with trastuzumab deruxtecan treatment

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainPatients who received trastuzumab deruxtecan (T-DXd) for human epidermal growth factor receptor 2 (HER2)-low m
World medicine December 16,2023
HER2-low metastatic breast cancer patients report preserved quality of life with trastuzumab deruxtecan treatment

HER2-low metastatic breast cancer patients report preserved quality of life with trastuzumab deruxtecan treatment

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainPatients who received trastuzumab deruxtecan (T-DXd) for human epidermal growth factor receptor 2 (HER2)-low m
World medicine December 16,2023
Empowering childhood cancer survivors to engage in physical activity

Empowering childhood cancer survivors to engage in physical activity

byUniversity of New South WalesCredit: Pixabay/CC0 Public DomainAbout 750 children are diagnosed with cancer in Australia each year. Thankfully, advancements in treatments have led to rising sur
World medicine December 16,2023
Empowering childhood cancer survivors to engage in physical activity

Empowering childhood cancer survivors to engage in physical activity

byUniversity of New South WalesCredit: Pixabay/CC0 Public DomainAbout 750 children are diagnosed with cancer in Australia each year. Thankfully, advancements in treatments have led to rising sur
World medicine December 16,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com